Skip to main content
Full access
Brief Reports
Published Online: 1 April 2016

Associations Between Magnitude of Child Maltreatment and Medicaid Expenditures for Psychotropic Medications

Abstract

Objective:

This study examined relationships between various measures of the severity of child maltreatment and expenditures on psychotropic drugs among children in the welfare system.

Methods:

Child participants (N=4,453) in the first National Survey of Child and Adolescent Well-Being (NSCAW) were linked to their Medicaid claims from 36 states. Three specifications for severity of maltreatment were developed. A two-part regression of logistic and generalized linear models of expenditures on psychotropic medications was estimated for each specification.

Results:

Physically abused children had higher odds (odds ratio [OR]=1.34) and neglected children had lower odds (OR=.76) of incurring psychotropic drug expenditures. Children who experienced the most severe level of harm had higher odds (OR=1.33) of medication use, compared with children without appreciable harm. No maltreatment specifications were associated with increased expenditures on psychotropic drugs.

Conclusions:

The magnitude of maltreatment affected odds of use of psychotropic drugs but had no effect on Medicaid expenditures for these drugs.
Children subjected to abuse or neglect are the principal consumers of child mental health services in the United States today. Half of all maltreated children have clinically significant emotional or behavioral problems (1), the costs of which are borne largely by Medicaid (2).
It is known that maltreatment is associated with the development of emotional or behavioral problems among children (1) and that Medicaid pays for treatment of those problems (3). However, it is unknown if there is a threshold level of severity above which maltreatment triggers a psychiatric disorder, which then affects service use and expenditures among these children. Quantifying any such threshold effects of maltreatment severity upon service use can further our knowledge of the sequelae of maltreatment.
Prospective studies appear to provide evidence for the cumulative effects of maltreatment. Around 40% of children with one report of maltreatment had at least one adverse mental, general medical, or adverse social condition; this rate rose to 92% among children with 12 or more reports (4). Experiencing one adverse exposure almost doubled the risk of overall poor health, and experiencing four or more adverse exposures nearly tripled the risk of general medical illness (5).
In this study, we quantified psychotropic medication expenditures associated with three measures of maltreatment severity among children in the child welfare system. Measuring the cost of psychotropic medication is important because spending on psychotropic drugs accounts for approximately half of all spending for the treatment of emotional and behavioral disorders (6) and because children in child welfare receive psychotropic medications at a rate that is two to three times higher than the rate among comparable children in the community (7).

Methods

The National Survey of Child and Adolescent Well-Being I (NSCAW), was the first nationally representative, longitudinal study of children and adolescents who come into contact with child protection agencies for suspected maltreatment (8). NSCAW data contain Social Security numbers (SSNs) of participants in 36 states, which we used to link 2,371 children in NSCAW to Medicaid records available from the Medicaid Analytic Extract, or MAX. The time frame of our study was 2000–2003, corresponding to the time frame of NSCAW administration. For NSCAW children without an SSN match, we used all unique combinations of five-digit ZIP code, date of birth, gender, and race-ethnicity to match children with their Medicaid record, for a total linked sample of 4,453 children.
We developed three specifications to quantify severity of maltreatment. First, assessments by the child’s welfare worker of physical abuse, sexual abuse, neglect, and abandonment were coded as binary variables. Our second operationalization was a cumulative model indicating the number of different types of abuse experienced by the child. Values ranged from 0, no maltreatment, to 4, all four types of maltreatment. Our third specification involved child welfare workers’ assessment of the level of harm caused by the abuse that led to the index report of maltreatment. For this variable, harm was categorized as none, mild, moderate, or severe.
Information about all other covariates, including child age, gender, and race-ethnicity, was provided by the child’s primary caregiver and was obtained from NSCAW. Children lived either at home with a permanent primary caregiver or out of home (family foster care or congregate care). Behavioral problems were indicated by a t score of ≥64 on the internalizing or externalizing scales of the Child Behavior Check List (CBCL) (9). General medical health was defined as fair or poor versus excellent, very good, or good. Rural residence was used as a proxy for the supply of health care resources. We included dummy variables for insurance type from the Medicaid enrollment files and included year dummies to control for secular trends. All child-level covariates were measured at entry of the child into the NSCAW study.
The outcome variable was the sum of all psychotropic expenditures incurred per child for each calendar year of the study, according to claims from the child’s Medicaid drug (RX) file. This amount was adjusted to 2012 dollars.
Psychotropic medication expenditures for each of the three specifications were estimated by using a two-part model with psychotropic drug expenditures per child per year as the outcome. In the first part, we used logistic regression to estimate the annual probability of having any medication expenditures. In the second part, we used a generalized linear model (GLM) with a log link and a gamma distribution to estimate the effects of severity of maltreatment on medication expenditures. We developed predictive margins from the second part of our models to increase their interpretability; for example, the predictive margin of expenditures for children with severe maltreatment is the average difference between expenditures in dollars for severely maltreated children and for children without apparent maltreatment, after the model was adjusted to control for the other variables. All analyses were performed in Stata, version 13.1 (10). This study was approved by the institutional review boards at our institutions.

Results

Of a total sample of 4,453 children, 2,157 (52%) were boys, and most were white (N=2,382, 53%) or African American (N=1,433, 32%), with smaller numbers of children of Hispanic, other, or mixed race-ethnicity. A total of 402 (9%) children were below age two. The majority of children (N=3,008, 70%) were determined by a child welfare worker to have been neglected. A total of 1,281 (29%) of children were physically abused, 568 (13%) were sexually abused, and 294 (6.6%) were abandoned. Around 250 (6%) children were not deemed to have incurred maltreatment. Most (N=3,336, 75%) children had experienced one type of maltreatment, 791 (18%) had experienced two types, 71 (2%) three types, and five (.1%) all four types of maltreatment. Irrespective of maltreatment determination, child welfare workers found no evidence of harm among 882 children (20%), mild harm among 1,143 (26%) children, moderate harm among 1,437 (32%) children, and severe harm among 991 (22%) children.
[A table summarizing the odds of a child’s incurring any psychotropic drug expenditures during a calendar year is available as an online supplement to this report.]
Table 1 presents predictive margins from the two-part model. Model 1 shows main effects of the four types of maltreatment and reveals that there was no statistically significant association between any of the abuse categories and expenditures for psychotropic medication. However, physically abused children had higher odds (odds ratio=1.34) and neglected children had lower odds (OR=.76) of incurring psychotropic drug expenditures (data not shown). Counts of different types of maltreatment (model 2) also were not associated with any significant increases in expenditures, nor was level of harm (model 3). Children who experienced the most severe level of harm had higher odds of medication use compared with children without appreciable harm (OR=1.33, data not shown).
TABLE 1. Predictive margins for Medicaid expenditures on psychotropic medication among children who experienced maltreatment, by operationalizations of severity of maltreatment and other variables
VariableModel 1Model 2Model 3
$95% CI$95% CI$95% CI
Abuse type (reference: no)      
 Physical50.98–61.18 to 163.15    
 Sexual144.62–24.57 to 313.81    
 Abandonment–36.68–153.59 to 80.23    
 Neglect290.22–24.15 to 604.59    
Count of abuse  35.15–53.60 to 123.91  
Severity of abuse (reference: none)      
 Mild    –42.43–194.63 to 109.77
 Moderate    –30.04–171.88 to 111.80
 Severe    137.44–34.30 to 309.19
Male (reference: female)175.41*76.95 to 273.86155.32*60.47 to 250.17153.42*59.68 to 247.16
Age (reference: 2–5)      
 6–11386.79*115.34 to 658.24367.07*103.31 to 630.83386.94*120.64 to 653.24
 12–13589.76*132.77 to 1,046.75588.69*132.99 to 1,044.39622.43*163.53 to 1,081.32
 ≥14619.67*230.61 to 1,008.74638.70*239.99 to 1,037.40677.30*273.81 to 1,080.78
Race-ethnicity (reference: white)      
 Black–212.07*–314.31 to –109.82–209.14*–311.95 to –106.34–215.67*–318.28 to –113.05
 Hispanic–25.46–185.27 to 134.36–21.12–184.93 to 142.69–30.05–193.94 to 133.85
 Other or unknown–75.76–238.37 to 86.85–58.18–233.61 to 117.25–56.33–224.22 to 111.56
CBCL subscale score ≥64 (reference: <64)a      
 Externalizing subscale465.01*346.08 to 583.94467.16*349.32 to 585.00464.30*350.18 to 578.42
 Internalizing subscale148.92*36.54 to 261.29160.87*47.20 to 274.54166.16*53.87 to 278.44
Insurance type (reference: none)      
 Other, non–mental health carve-out455.57*–67.71 to 978.85423.06–97.22 to 943.35513.68*–53.03 to 1080.39
 Primary care case management–303.90*–409.67 to –198.14–304.91*–410.87 to –198.95–283.11*–388.39 to –177.82
Out-of-home placement (reference: no)152.13*52.24 to 252.01154.73*55.34 to 254.12124.77*19.87 to 229.68
Fair or poor health (reference: good)–197.3–506.56 to 111.95–193.16–495.73 to 109.41–184.81–498.37 to 128.75
Rural residence (reference: no)–4.14–131.08 to 122.81–15.96–142.51 to 110.59–27.52–151.77 to 96.74
a
CBCL, Child Behavior Check List. Scores ≥64 indicate the presence of behavioral problems.
*
p<.05
Other covariates, however, were significantly associated with amount of expenditures. Male gender, increasing age, white race-ethnicity, out-of-home placement, and clinical scores for the externalizing and internalizing subscales of the CBCL all increased expenditures for these medications. Children with primary care case management insurance had lower expenditures for medications, conditional on use, compared with children in Medicaid fee-for-service insurance.

Discussion and Conclusions

The key finding of this study was that severity of maltreatment had no additional significant effect on drug expenditures after the analyses controlled for externalizing and internalizing child behaviors. One possible explanation for this finding is that decisions about the amount, type, and duration of use of psychotropic drugs are directed toward managing the sequelae of maltreatment, and not toward managing maltreatment per se. In other words, clinicians use medications in an attempt to alleviate the emotional, cognitive, and behavioral effects of abuse and neglect, grouped into disorders.
This possibility was reflected in the robust relationship between expenditures and CBCL scores, with CBCL scores mediating the relationship between maltreatment and drug expenditures. Children scoring in the clinical range of the CBCL’s externalizing subscale incurred about $465 more in expenditures for psychotropic drugs compared with children whose CBCL scores were below that cutpoint. A significant relationship existed between scoring in the clinical range of the CBCL’s internalizing subscale and higher psychotropic costs (about $150–$160 more on average). It appears that CBCL scores in this study were proxies for disorders that warrant treatment with psychotropic drugs.
However, effects for magnitude of maltreatment on the odds of psychotropic medication use were observed. Physically abused children had higher odds of psychotropic drug use compared with those without histories of physical abuse. The relationship between abuse type and odds of medication use has been the focus of prior studies (7,11), and our findings are generally consistent with those of other scholars.
All of these findings were subject to a few limitations. We did not observe children in managed care environments, the effects of which on drug expenditures cannot be estimated at a national level at the present time. Second, our data, while unique, were dated, which may limit generalizability to current medications and expenditures. Finally, maltreatment is underreported, and some forms of maltreatment (such as verbal abuse) were not captured in our data, and both were limitations that may downwardly bias our observed estimates.
Identifying and deploying better instruments to capture the psychological sequelae of child maltreatment will allow greater refinement of the costs to Medicaid agencies of child abuse and neglect nationwide.

Footnotes

This study was funded by the National Institute of Mental Health (NIMH) (R01 MH092312 and T32MH019960) and the Agency for Healthcare Research and Quality (R01 HS020269). The National Survey of Child and Adolescent Well-Being was developed under contract with the Administration on Children, Youth, and Families, U.S. Department of Health and Human Services (ACYF/DHHS). The data were provided by the National Data Archive on Child Abuse and Neglect.
The information and opinions expressed herein reflect solely the position of the authors. Nothing herein should be construed to indicate the support or endorsement of its content by ACYF/DHHS, NIMH, or the National Institutes of Health.

Supplementary Material

File (appi.ps.201500211.ds001.pdf)

References

1.
Burns BJ, Phillips SD, Wagner HR, et al: Mental health need and access to mental health services by youths involved with child welfare: a national survey. Journal of the American Academy of Child and Adolescent Psychiatry 43:960–970, 2004
2.
Raghavan R, Leibowitz AA: Medicaid and mental health care for children in the child welfare system; in Child Protection: Using Research to Improve Policy and Practice. Edited by Haskins R, Wulczyn F, Webb MB. Washington, DC, Brookings, 2007
3.
Raghavan R, Brown DS, Allaire BT, et al: Medicaid expenditures on psychotropic medications for maltreated children: a study of 36 states. Psychiatric Services 65:1445–1451, 2014
4.
Jonson-Reid M, Kohl PL, Drake B: Child and adult outcomes of chronic child maltreatment. Pediatrics 129:839–845, 2012
5.
Flaherty EG, Thompson R, Litrownik AJ, et al: Effect of early childhood adversity on child health. Archives of Pediatrics and Adolescent Medicine 160:1232–1238, 2006
6.
Frank RG, Goldman HH, McGuire TG: Trends in mental health cost growth: an expanded role for management? Health Affairs 28:649–659, 2009
7.
Raghavan R, Zima BT, Andersen RM, et al: Psychotropic medication use in a national probability sample of children in the child welfare system. Journal of Child and Adolescent Psychopharmacology 15:97–106, 2005
8.
Dowd K, Kinsey S, Wheeless A, et al: National Survey of Child and Adolescent Well-Being: Combined Waves 1–4. Data File User’s Manual. Ithaca, NY, National Data Archive on Child Abuse and Neglect, 2006
9.
Achenbach TM: Manual for the Child Behavior Checklist/2-3 and 1992 Profile. Burlington, Vt, Department of Psychiatry, 1992
10.
Stata Statistical Software: Release 13.1. College Station, Tex, StataCorp LP, 2013
11.
Samuels B: Managing Psychotropic Medications for Children and Youth in Foster Care. Washington, DC, Administration for Children and Health, 2012. Available at www.acf.hhs.gov/blog/2012/08/managing-psychotropic-medications-for-children-and-youth-in-foster-care

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Dulcimer, probably by Robert Kelly. White wood with walnut, accession #2005.708.1. The Colonial Williamsburg Foundation, museum purchase.

Psychiatric Services
Pages: 916 - 919
PubMed: 27032658

History

Received: 28 May 2015
Revision received: 28 September 2015
Revision received: 7 December 2015
Accepted: 18 December 2015
Published online: 1 April 2016
Published in print: August 01, 2016

Authors

Details

Ramesh Raghavan, M.D., Ph.D.
Dr. Raghavan is with the School of Social Work, Rutgers, The State University of New Jersey, New Brunswick. Dr. Brown and Ms. Ross are with the George Warren Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri. Mr. Allaire is with RTI International, Research Triangle Park, North Carolina. Dr. Landsverk is with the Child and Adolescent Services Research Center, Rady Children's Hospital, San Diego. Send correspondence to Ms. Ross (e-mail: [email protected]).
Derek S. Brown, Ph.D.
Dr. Raghavan is with the School of Social Work, Rutgers, The State University of New Jersey, New Brunswick. Dr. Brown and Ms. Ross are with the George Warren Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri. Mr. Allaire is with RTI International, Research Triangle Park, North Carolina. Dr. Landsverk is with the Child and Adolescent Services Research Center, Rady Children's Hospital, San Diego. Send correspondence to Ms. Ross (e-mail: [email protected]).
Benjamin T. Allaire, M.S.
Dr. Raghavan is with the School of Social Work, Rutgers, The State University of New Jersey, New Brunswick. Dr. Brown and Ms. Ross are with the George Warren Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri. Mr. Allaire is with RTI International, Research Triangle Park, North Carolina. Dr. Landsverk is with the Child and Adolescent Services Research Center, Rady Children's Hospital, San Diego. Send correspondence to Ms. Ross (e-mail: [email protected]).
Raven E. Ross, M.S.W.
Dr. Raghavan is with the School of Social Work, Rutgers, The State University of New Jersey, New Brunswick. Dr. Brown and Ms. Ross are with the George Warren Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri. Mr. Allaire is with RTI International, Research Triangle Park, North Carolina. Dr. Landsverk is with the Child and Adolescent Services Research Center, Rady Children's Hospital, San Diego. Send correspondence to Ms. Ross (e-mail: [email protected]).
John Landsverk, Ph.D.
Dr. Raghavan is with the School of Social Work, Rutgers, The State University of New Jersey, New Brunswick. Dr. Brown and Ms. Ross are with the George Warren Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri. Mr. Allaire is with RTI International, Research Triangle Park, North Carolina. Dr. Landsverk is with the Child and Adolescent Services Research Center, Rady Children's Hospital, San Diego. Send correspondence to Ms. Ross (e-mail: [email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

National Institute of Mental Health10.13039/100000025: HHSN271201200644P, R01 MH092312, T32MH019960
Agency for Healthcare Research and Quality10.13039/100000133: R01 HS020269

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share